映恩生物-B(09606)拟发行人民币股份于上交所科创板上市

Core Viewpoint - The company, Ying'en Biotechnology-B (09606), plans to issue ordinary shares to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with trading in Renminbi [1] Group 1 - The board of directors has resolved to propose the issuance of Renminbi shares, subject to market conditions, further board approval, shareholder approval at the general meeting, and necessary regulatory approvals [1] - As of the date of the announcement, there are no other plans regarding the proposed issuance of Renminbi shares, nor has the board made any applications to relevant regulatory bodies [1]